After nosediving 53% in 8 weeks, could this be one of the best AIM stocks to buy right now?

Insiders have taken advantage of the recent fall in the YouGov share price. Our writer considers whether he should do the same and buy the AIM stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Alternative Investment Market (AIM) stocks tend to be more volatile than those on the main market. That’s because the index is home to many high-growth companies that sometimes run into unforeseen problems.

However, even by AIM standards, the 53% fall in the YouGov (LSE:YOU) share price — since 31 May — is spectacular and unexpected.

Created with Highcharts 11.4.3YouGov Plc PriceZoom1M3M6MYTD1Y5Y10YALL25 Jul 20198 Apr 2025Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25202020202021202120222022202320232024202420252025www.fool.co.uk

Impressive growth

It’s a surprise because the company has a long track record of steadily increasing its earnings. During the 13 years up to and including the year ended 31 July 2023 (FY23), it grew its earnings per share in 12 of them.

Should you invest £1,000 in Gsk right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Gsk made the list?

See the 6 stocks

However, on 20 June, the company issued a profits warning for FY24.

The data and analytics technology group announced that it expects earnings to be 32% below analysts’ consensus forecast.

Its share price crashed 46% on the day. This compounded an already disappointing run for shareholders. From the start of 2024 to just before the announcement, the shares had fallen nearly 30%.

But as Warren Buffett famously said: “Be fearful when others are greedy, and greedy when others are fearful”.

Maybe that’s why three directors of the company have recently bought 90,496 shares at a weighted average price of £4.15. They’re collectively sitting on a profit of nearly £39,000.

My own view

When I looked at the company in February I decided to put it on my watchlist for when I next had some spare cash.

I was impressed with the firm’s growth record. And I thought the move towards machine learning and artificial intelligence (AI) would lead to further demand for the data that the business provides.

Data is often described as the most valuable asset in the world. And YouGov has loads of it.

Even after the share price fall — largely as a result of lower-than-anticipated sales in its Data Products division and reported challenges in Germany, Austria and Switzerland — I remain a fan of the firm.

I view its problems as a temporary blip rather than a sign of anything fundamentally wrong. The shares are now trading on a lower multiple than before the profit warning and I do think the market has overreacted to the bad news.

However, I don’t want to invest at the moment.

That’s because my confidence in management has taken a bit of a knock. It wasn’t that long ago — on 26 March to be precise — that YouGov said it was “confident in achieving current market expectations for the full year”.

Oh dear.

I’m also concerned about the company’s relatively high gearing. This is something I’m going to keep an eye one.

YouGov has grown largely as a result of acquiring other businesses. Much of this expansion has been funded by debt. On 31 January 2024, the company’s balance sheet included borrowings of £213.7m. This is £24.7m more than the book value (equity) of the firm.

For these reasons, I want to wait and see the next trading announcement (scheduled for 6 August) before reviewing the situation once more.

Should you invest £1,000 in Gsk right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Gsk made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Beard has no position in any of the shares mentioned. The Motley Fool UK has recommended YouGov Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

I was wrong about the Tesla stock price!

Tesla stock's been affected more than most by ‘Liberation Day’. But our writer has other concerns about Elon Musk’s company.

Read more »

Investing Articles

What’s happening to the Rolls-Royce share price now?

The Rolls-Royce share price has taken a knock from US trade tariffs, but it's still gained more than 50% in…

Read more »

Investing Articles

10 UK shares that are 50% or more off their 52-week highs

These UK shares have been hit hard. And Edward Sheldon believes there could be some opportunities for those with a…

Read more »

Man smiling and working on laptop
Investing Articles

Could IAG’s share price surge over the next year? These analysts think so!

IAG's share price has sunk, reflecting growing concerns over the impact of trade wars on airline profits. Is this a…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£10,000 invested in Apple shares last week is now worth…

Apple shares are down 18% over the past week. It’s a truly phenomenal downward movement, but investors may want to…

Read more »

Investing Articles

Are shares like Tesco a safe haven for investors?

Christopher Ruane sees a lot to like about Tesco shares. But does he see them as a safe heaven in…

Read more »

Young mixed-race woman looking out of the window with a look of consternation on her face
Investing Articles

The 2025 stock market sell-off could be a once-in-a-decade opportunity to build wealth in an ISA

If a long-term investor has cash sitting in an investment ISA, now could be a good time to put some…

Read more »

pensive bearded business man sitting on chair looking out of the window
Investing Articles

Is now a good time to start buying shares?

Stock market turbulence can be alarming, but it can also offer opportunity. Our writer considers whether now could be the…

Read more »